Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Revista Medica De Chile|December 25, 2003
[Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women]Arnaldo Porcile, Enrique Gallardo, Patricia Duarte, et al.
Critical Reviews in Oncology/Hematology|July 23, 2013
Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxelEnrique Gallardo, José Ángel Arranz, José Pablo Maroto, et al.
Targeted Oncology|March 24, 2018
Prognostic and Predictive Factors for Renal Cell CarcinomaCristina Suárez, Marc Campayo, Romà Bastús, et al.
Journal of Medical Economics|June 15, 2022
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in SpainAndrés Muñoz, Enrique Gallardo, Giancarlo Agnelli, et al.
Frontiers in Oncology|May 23, 2024
EORTC 2238 "De-Escalate": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitorsGuillaume Grisay, Fabio Turco, Saskia Litiere, et al.
Marine Drugs|October 21, 2009
Phase II study of biweekly plitidepsin as second-line therapy for advanced or metastatic transitional cell carcinoma of the urotheliumHerlinde Dumez, Enrique Gallardo, Stephane Culine, et al.
Thrombosis and Haemostasis|May 13, 2025
Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special SituationsCristina Marzo, Teresa Solanich, Dolors Tassies, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 15, 2010
Haemolytic uraemic syndrome associated with gemcitabineIrene Moya-Horno, Rosa Querol Niñerola, Teresa Bonfill Abella, et al.
The Oncologist|August 22, 2014
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinomaJoaquim Bellmunt, Cristina Suarez, Enrique Gallardo, et al.
Cancers|October 13, 2021
Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working GroupJosé Rubio-Briones, Ferran Algaba, Enrique Gallardo, et al.
Pageof 7